Houston, TX 的 間質性肺病 臨床試驗
12 項針對 間質性肺病 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- Baylor College of Medicine, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
招募中3 期
- GSK Investigational Site, Houston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
招募中2 期
- Baylor College of Medicine, Houston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Houston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中觀察性研究
- Houston Methodist, Houston
- University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中觀察性研究
- Baylor College of Medicine, Houston
- Houston Methodist Lung Center, Houston
- The University of Texas Health Science Center At Houston, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- Houston Methodist Hospital, Houston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- Houston Methodist Outpatient Center, Houston
- The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
招募中觀察性研究
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
招募中2 期
- aTyr Investigative Site, Houston
其他城市的 間質性肺病 試驗
- New York City, NY18 項研究
- Philadelphia, PA16 項研究
- Los Angeles, CA14 項研究
- Kansas City, KS13 項研究
- Durham, NC13 項研究
- Charleston, SC13 項研究
- Chicago, IL12 項研究
- Aurora, CO11 項研究
- Ann Arbor, MI11 項研究
- Phoenix, AZ9 項研究
- Salt Lake City, UT9 項研究
- Boston, MA9 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。